| Filed On | Filing |
|---|---|
| 12 Nov 2026 | 8-K: Results of Operations and Financial Condition |
| 12 Nov 2026 | 10-Q |
| 02 Oct 2026 |
Form 4: Raben David, Chief Medical Officer
Granted 575,000 Stock Option (Right to Buy) |
| 02 Oct 2026 |
Form 3: Raben David, Chief Medical Officer
No securities owned |
| 14 Aug 2026 | SCHEDULE 13G |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 11 Aug 2026 |
8-K: Results of Operations and Financial Condition
FORTIFY, a Phase 1b indication expansion trial of PLN-101095, |
| 11 Aug 2026 | 10-Q |
| 13 Jul 2026 |
Form 3: Iannone Robert, Director
No securities owned |
| 13 Jul 2026 |
Form 4: Iannone Robert, Director
Granted 60,000 Stock Option (Right to Buy) |
| 13 Jul 2026 |
Form 3: Borellini Flavia, Director
No securities owned |
| 13 Jul 2026 |
Form 4: Borellini Flavia, Director
Granted 60,000 Stock Option (Right to Buy) |
| 13 Jul 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On July 9, 2026 (the “Effective Date”), the Board of Directors (the “Board”) of Pliant Therapeutics, Inc. (the “Company”) increased the authorized size of the Board from seven to nine members, and, upon the recommendation of the Nominati... |
| 12 Jun 2026 |
Form 4: Crowell Gayle A, Director
Granted 70,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Mccourt Thomas A, Director
Granted 70,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Krognes Steve E., Director
Granted 70,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Curnutte John T, Director
Granted 70,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Huh Hoyoung, Director
Granted 70,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Cline Darren S, Director
Granted 70,000 Stock Option (Right to Buy) |
| 11 Jun 2026 |
8-K: Submission of Matters to a Vote of Security Holders
The 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Pliant Therapeutics, Inc. (the “Company”) was held on June 11, 2026. As of April 15, 2026, the record date for the Annual Meeting, there were 61,914,664 shares of the Comp... |
Loading...